Published by Reuters UKBy Maggie Fick LONDON (Reuters) - British drugmaker GSK's HIV treatment division, ViiV Healthcare, published data on Wednesday … [Read more...] about GSK’s ViiV says study shows its long-acting HIV shot as effective as Gilead’s daily pill
Viiv Healthcare
Injectable Long-Acting PrEP Shown to Be 69 Percent More Effective at Averting HIV Infection Than Truvada
A new injectable form of PrEP (pre-exposure prophylaxis) from ViiV Healthcare administered every two months has been shown to be 69 percent more … [Read more...] about Injectable Long-Acting PrEP Shown to Be 69 Percent More Effective at Averting HIV Infection Than Truvada